£6.0M
The investment round was led by the Investment Fund for Northern Ireland to support international commercial expansion and product development.
N
Neurovalens
Neurovalens creates wearable devices that stimulate the brain to address metabolic and health issues.
Northern Ireland, UK—Founded 2015
£16.8MTotal raised
Neurovalens develops wearable technology that combines neuroscience with medical applications to address health and metabolic issues.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Neurovalens's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Jason McKeown
CEO
Jason brings medical and academic experience as the chief executive of Neurovalens, alongside visiting roles at Stanford University and the University of California, San Diego.
LinkedInInvestors
- £6.0M
- £5.1MAngel CoFundFollow-on
TechstartFollow-on
- £4.6M
- £1.1M
Funding history
£5.1M
The financing will support clinical trials, product development and team expansion as the business pursues international regulatory approvals.
£4.6M
The Belfast-based health technology firm secured Series A backing from investors including Wharton Asset Management and IQ Capital to advance its neurological research and medical trials.
£1.1M
The funding round was led by the Angel CoFund, Beltrae Partners, and TechStart NI.